Integrative Analysis of Epigenetic Modulation in Melanoma Cell Response to Decitabine: Clinical ImplicationsRuth Halaban(Yale University), Jan J. Enghild(Indiana University School of Medicine)PLoS ONEFebruary 20, 200910.1371/journal.pone.0004563Cited by 58SaveCiteExport RISWatch citationsRelated PapersPLX4032, a selective BRAF <sup>V600E</sup> kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF <sup>WT</sup> melanoma cells|Pigment Cell & Melanoma Research|2010|322Desmosome Signaling: INHIBITION OF p38MAPK PREVENTS PEMPHIGUS VULGARIS IgG-INDUCED CYTOSKELETON REORGANIZATION|UNC Libraries|2021|9